TABLE 5.

Comparative plasma and kidney pharmacokinetics of tanshinol in rats receiving an i.v. bolus dose of tanshinol solution (2–200 mg/kg)

The rat blood and kidney tissue samples were collected at 5 and 30 minutes and 1 and 2 hours after dosing. Urine samples were collected 0–24 hours after dosing. The details of the rat PK study are described in Materials and Methods (the third rat PK study).

PK ParameterDosage
251550200
mg/kg
Plasma data
 C5min (μM)15.5 ± 1.536.7 ± 2.998.7 ± 17.9388 ± 481403 ± 98
 AUC0–∞ (μM⋅h)4.33 ± 0.4511.0 ± 1.031.2 ± 5.5125 ± 23504 ± 61
 t1/2 (h)0.278 ± 0.0170.285 ± 0.0100.260 ± 0.0270.269 ± 0.0220.259 ± 0.014
 MRT (h)0.272 ± 0.0300.252 ± 0.0040.237 ± 0.0310.288 ± 0.0020.328 ± 0.009
 VSS (l/kg)0.635 ± 0.0230.582 ± 0.0490.578 ± 0.0520.595 ± 0.0970.662 ± 0.067
 CLtot, p (l/h/kg)2.35 ± 0.252.31 ± 0.202.48 ± 0.452.07 ± 0.342.02 ± 0.26
Urine data
 Cum.Ae (μmol)1.48 ± 0.063.75 ± 0.2912.3 ± 1.144.2 ± 2.9192 ± 18
 fe-U (%)61.5 ± 3.659.7 ± 6.866.3 ± 7.573.3 ± 5.777.9 ± 6.7
 CLR (l/h/kg)1.44 ± 0.101.37 ± 0.051.62 ± 0.111.50 ± 0.151.56 ± 0.06
Kidney data
 C5min (μM)118 ± 37278 ± 791083 ± 4103199 ± 10469671 ± 1536
 AUC0–∞ (μM⋅h)22.7 ± 6.967.9 ± 18.0268 ± 97899 ± 3093552 ± 518
 t1/2 (h)0.277 ± 0.0100.250 ± 0.0310.238 ± 0.0030.267 ± 0.0160.256 ± 0.007
 MRT (h)0.232 ± 0.0110.197 ± 0.0280.172 ± 0.0080.214 ± 0.0100.254 ± 0.011
 CLR,c-u (l/h/kg)0.289 ± 0.0750.282 ± 0.0640.261 ± 0.0610.269 ± 0.0620.272 ± 0.017
  • AUC0–∞, area under the plasma concentration-time curve from 0 to infinity; CLR,c-u, renal clearance by the cellular efflux into urine across the apical brush border membrane; CLR, renal clearance; CLtot,p, total plasma clearance; C5min, concentration at 5 min after dosing; Cum.Ae, cumulative amount excreted; MRT, mean residence time; t1/2, elimination half-life; VSS, apparent volume of distribution at steady state.